{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T17:33:57Z","timestamp":1772732037952,"version":"3.50.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12941-017-0249-2","type":"journal-article","created":{"date-parts":[[2017,11,25]],"date-time":"2017-11-25T02:15:42Z","timestamp":1511576142000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review"],"prefix":"10.1186","volume":"16","author":[{"given":"David M.","family":"Jacobs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Courtney","family":"Safir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faisal","family":"Minhaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gauri G.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,25]]},"reference":[{"issue":"9","key":"249_CR1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1473-3099(13)70190-7","volume":"13","author":"LS Munoz-Price","year":"2013","unstructured":"Munoz-Price LS, Poirel L, Bonomo RA, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13(9):785\u201396.","journal-title":"Lancet Infect Dis."},{"issue":"10","key":"249_CR2","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.1128\/AAC.01019-15","volume":"59","author":"JD Pitout","year":"2015","unstructured":"Pitout JD, Nordmann P, Poirel L. Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother. 2015;59(10):5873\u201384.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"249_CR3","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1128\/AAC.01222-13","volume":"58","author":"ME Falagas","year":"2014","unstructured":"Falagas ME, Lourida P, Poulikakos P, Rafailidis PI, Tansarli GS. Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence. Antimicrob Agents Chemother. 2014;58(2):654\u201363.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"249_CR4","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1128\/AAC.06268-11","volume":"56","author":"ZA Qureshi","year":"2012","unstructured":"Qureshi ZA, Paterson DL, Potoski BA, et al. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob Agents Chemother. 2012;56(4):2108\u201313.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"249_CR5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jhin.2015.06.018","volume":"92","author":"A Hoxha","year":"2016","unstructured":"Hoxha A, Karki T, Giambi C, et al. Attributable mortality of carbapenem-resistant Klebsiella pneumoniae infections in a prospective matched cohort study in Italy, 2012\u20132013. J Hosp Infect. 2016;92(1):61\u20136.","journal-title":"J Hosp Infect"},{"issue":"2","key":"249_CR6","doi-asserted-by":"crossref","first-page":"ofv050","DOI":"10.1093\/ofid\/ofv050","volume":"2","author":"HJ Morrill","year":"2015","unstructured":"Morrill HJ, Pogue JM, Kaye KS, LaPlante KL. Treatment options for carbapenem-resistant Enterobacteriaceae infections. Open Forum Infect Dis. 2015;2(2):ofv050.","journal-title":"Open Forum Infect Dis."},{"issue":"12","key":"249_CR7","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/jac\/dks301","volume":"67","author":"KZ Vardakas","year":"2012","unstructured":"Vardakas KZ, Tansarli GS, Rafailidis PI, Falagas ME. Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum beta-lactamases: a systematic review and meta-analysis. J Antimicrob Chemother. 2012;67(12):2793\u2013803.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"249_CR8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1469-0691.2012.03821.x","volume":"18","author":"R Canton","year":"2012","unstructured":"Canton R, Akova M, Carmeli Y, et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect. 2012;18(5):413\u201331.","journal-title":"Clin Microbiol Infect"},{"key":"249_CR9","unstructured":"Organization WH. Antimicrobial resistance: global report on surveillance. World Health Organization; 2014."},{"issue":"9","key":"249_CR10","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/1469-0691.12719","volume":"20","author":"P Nordmann","year":"2014","unstructured":"Nordmann P, Poirel L. The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. Clin Microbiol Infect. 2014;20(9):821\u201330.","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"249_CR11","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/1469-0691.12697","volume":"20","author":"LS Tzouvelekis","year":"2014","unstructured":"Tzouvelekis LS, Markogiannakis A, Piperaki E, Souli M, Daikos GL. Treating infections caused by carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect. 2014;20(9):862\u201372.","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"249_CR12","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1093\/jac\/dkv086","volume":"70","author":"M Tumbarello","year":"2015","unstructured":"Tumbarello M, Trecarichi EM, De Rosa FG, et al. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. J Antimicrob Chemother. 2015;70(7):2133\u201343.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"249_CR13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1586\/eri.12.162","volume":"11","author":"N Petrosillo","year":"2013","unstructured":"Petrosillo N, Giannella M, Lewis R, Viale P. Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art. Expert Rev Anti Infect Ther. 2013;11(2):159\u201377.","journal-title":"Expert Rev Anti Infect Ther."},{"issue":"6","key":"249_CR14","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/cid\/ciw805","volume":"64","author":"LJ Rojas","year":"2017","unstructured":"Rojas LJ, Salim M, Cober E, et al. Colistin resistance in carbapenem-resistant Klebsiella pneumoniae: laboratory detection and impact on mortality. Clin Infect Dis. 2017;64(6):711\u20138.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"249_CR15","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.cmi.2015.08.001","volume":"21","author":"DR Giacobbe","year":"2015","unstructured":"Giacobbe DR, Del Bono V, Trecarichi EM, et al. Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case\u2013control\u2013control study. Clin Microbiol Infect. 2015;21(12):1106\u20138.","journal-title":"Clin Microbiol Infect."},{"issue":"2","key":"249_CR16","doi-asserted-by":"crossref","first-page":"e02121","DOI":"10.1128\/AAC.02121-16","volume":"61","author":"J Diep","year":"2017","unstructured":"Diep J, Jacobs DM, Sharma R, et al. Polymyxin B in combination with rifampin and meropenem against polymyxin B-resistant KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2017;61(2):e02121.","journal-title":"Antimicrob Agents Chemother."},{"issue":"7","key":"249_CR17","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/jac\/dku065","volume":"69","author":"P Gaibani","year":"2014","unstructured":"Gaibani P, Lombardo D, Lewis RE, et al. In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates. J Antimicrob Chemother. 2014;69(7):1856\u201365.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"249_CR18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1399-3062.2012.00742.x","volume":"14","author":"EJ Ariza-Heredia","year":"2012","unstructured":"Ariza-Heredia EJ, Patel R, Blumberg EA, et al. Outcomes of transplantation using organs from a donor infected with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae. Transpl Infect Dis. 2012;14(3):229\u201336.","journal-title":"Transpl Infect Dis."},{"issue":"10","key":"249_CR19","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.1128\/AAC.00655-15","volume":"59","author":"JF Camargo","year":"2015","unstructured":"Camargo JF, Simkins J, Beduschi T, et al. Successful treatment of carbapenemase-producing pandrug-resistant Klebsiella pneumoniae bacteremia. Antimicrob Agents Chemother. 2015;59(10):5903\u20138.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"249_CR20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jinf.2014.10.001","volume":"70","author":"NG Chua","year":"2015","unstructured":"Chua NG, Zhou YP, Tan TT, et al. Polymyxin B with dual carbapenem combination therapy against carbapenemase-producing Klebsiella pneumoniae. J Infect. 2015;70(3):309\u201311.","journal-title":"J Infect"},{"key":"249_CR21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijid.2014.01.028","volume":"25","author":"J Sanctis de","year":"2014","unstructured":"de Sanctis J, Teixeira L, van Duin D, et al. Complex prosthetic joint infections due to carbapenemase-producing Klebsiella pneumoniae: a unique challenge in the era of untreatable infections. Int J Infect Dis. 2014;25:73\u20138.","journal-title":"Int J Infect Dis."},{"issue":"5","key":"249_CR22","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1128\/AAC.02399-12","volume":"57","author":"H Giamarellou","year":"2013","unstructured":"Giamarellou H, Galani L, Baziaka F, Karaiskos I. Effectiveness of a double-carbapenem regimen for infections in humans due to carbapenemase-producing pandrug-resistant Klebsiella pneumoniae. Antimicrob Agents Chemother. 2013;57(5):2388\u201390.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"249_CR23","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s15010-013-0578-9","volume":"42","author":"E Lemmenmeier","year":"2014","unstructured":"Lemmenmeier E, Kohler P, Bruderer T, Goldenberger D, Kleger GR, Schlegel M. First documented outbreak of KPC-2-producing Klebsiella pneumoniae in Switzerland: infection control measures and clinical management. Infection. 2014;42(3):529\u201334.","journal-title":"Infection"},{"issue":"3","key":"249_CR24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/nmi2.40","volume":"2","author":"C Marquez","year":"2014","unstructured":"Marquez C, Ingold A, Echeverria N, et al. Emergence of KPC-producing Klebsiella pneumoniae in Uruguay: infection control and molecular characterization. New Microbes New Infect. 2014;2(3):58\u201363.","journal-title":"New Microbes New Infect."},{"issue":"3","key":"249_CR25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1399-3062.2009.00374.x","volume":"11","author":"AJ Mathers","year":"2009","unstructured":"Mathers AJ, Cox HL, Bonatti H, et al. Fatal cross infection by carbapenem resistant Klebsiella in two liver transplant recipients. Transpl Infect Dis. 2009;11(3):257\u201365.","journal-title":"Transpl Infect Dis."},{"issue":"2","key":"249_CR26","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/1060028013510487","volume":"48","author":"S Nevrekar","year":"2014","unstructured":"Nevrekar S, Cunningham KC, Greathouse KM, Panos NG. Dual intraventricular plus systemic antibiotic therapy for the treatment of Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae ventriculitis. Ann Pharmacother. 2014;48(2):274\u20138.","journal-title":"Ann Pharmacother"},{"key":"249_CR27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijid.2015.01.011","volume":"33","author":"A Oliva","year":"2015","unstructured":"Oliva A, Mascellino MT, Cipolla A, et al. Therapeutic strategy for pandrug-resistant Klebsiella pneumoniae severe infections: short-course treatment with colistin increases the in vivo and in vitro activity of double carbapenem regimen. Int J Infect Dis. 2015;33:132\u20134.","journal-title":"Int J Infect Dis."},{"issue":"1","key":"249_CR28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijantimicag.2013.09.010","volume":"43","author":"K Pontikis","year":"2014","unstructured":"Pontikis K, Karaiskos I, Bastani S, et al. Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria. Int J Antimicrob Agents. 2014;43(1):52\u20139.","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"249_CR29","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.resinv.2015.01.001","volume":"53","author":"B Viaggi","year":"2015","unstructured":"Viaggi B, Sbrana F, Malacarne P, Tascini C. Ventilator-associated pneumonia caused by colistin-resistant KPC-producing Klebsiella pneumoniae: a case report and literature review. Respir Investig. 2015;53(3):124\u20138.","journal-title":"Respir Investig."},{"issue":"5","key":"249_CR30","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/iwj.12528","volume":"13","author":"E Virgilio","year":"2016","unstructured":"Virgilio E, Castaldo P, Catta F, Tarantino G, Cavallini M. Abdominal surgical site infection due to Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Int Wound J. 2016;13(5):1075\u20136.","journal-title":"Int Wound J."},{"issue":"3","key":"249_CR31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/00365548.2013.861608","volume":"46","author":"B Balandin Moreno","year":"2014","unstructured":"Balandin Moreno B, Fernandez Simon I, Pintado Garcia V, et al. Tigecycline therapy for infections due to carbapenemase-producing Klebsiella pneumoniae in critically ill patients. Scand J Infect Dis. 2014;46(3):175\u201380.","journal-title":"Scand J Infect Dis"},{"issue":"3","key":"249_CR32","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.nefro.2015.02.002","volume":"35","author":"F Cicora","year":"2015","unstructured":"Cicora F, Mos F, Roberti J. Kidney transplant recipients infected with blaKPC-2-producing Klebsiella pneumoniae. Nefrologia. 2015;35(3):340\u20133.","journal-title":"Nefrologia."},{"issue":"10","key":"249_CR33","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1111\/ajt.12424","volume":"13","author":"CJ Clancy","year":"2013","unstructured":"Clancy CJ, Chen L, Shields RK, et al. Epidemiology and molecular characterization of bacteremia due to carbapenem-resistant Klebsiella pneumoniae in transplant recipients. Am J Transpl. 2013;13(10):2619\u201333.","journal-title":"Am J Transpl"},{"issue":"4","key":"249_CR34","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1128\/AAC.02166-13","volume":"58","author":"GL Daikos","year":"2014","unstructured":"Daikos GL, Tsaousi S, Tzouvelekis LS, et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob Agents Chemother. 2014;58(4):2322\u20138.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"249_CR35","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10096-014-2233-5","volume":"34","author":"MP Freire","year":"2015","unstructured":"Freire MP, Pierrotti LC, Filho HH, et al. Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae in cancer patients. Eur J Clin Microbiol Infect Dis. 2015;34(2):277\u201386.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"249_CR36","doi-asserted-by":"crossref","first-page":"O117","DOI":"10.1111\/1469-0691.12341","volume":"20","author":"F Kontopidou","year":"2014","unstructured":"Kontopidou F, Giamarellou H, Katerelos P, et al. Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome and therapeutic options. Clin Microbiol Infect. 2014;20(2):O117\u201323.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"249_CR37","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s15010-013-0547-3","volume":"42","author":"C Lubbert","year":"2014","unstructured":"Lubbert C, Becker-Rux D, Rodloff AC, et al. Colonization of liver transplant recipients with KPC-producing Klebsiella pneumoniae is associated with high infection rates and excess mortality: a case\u2013control analysis. Infection. 2014;42(2):309\u201316.","journal-title":"Infection"},{"issue":"3","key":"249_CR38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jinf.2009.01.010","volume":"58","author":"HC Maltezou","year":"2009","unstructured":"Maltezou HC, Giakkoupi P, Maragos A, et al. Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece). J Infect. 2009;58(3):213\u20139.","journal-title":"J Infect"},{"issue":"10","key":"249_CR39","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1093\/jac\/dks239","volume":"67","author":"D Morris","year":"2012","unstructured":"Morris D, Boyle F, Morris C, et al. Inter-hospital outbreak of Klebsiella pneumoniae producing KPC-2 carbapenemase in Ireland. J Antimicrob Chemother. 2012;67(10):2367\u201372.","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"249_CR40","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1016\/j.transproceed.2014.09.160","volume":"46","author":"E Mouloudi","year":"2014","unstructured":"Mouloudi E, Massa E, Piperidou M, et al. Tigecycline for treatment of carbapenem-resistant Klebsiella pneumoniae infections after liver transplantation in the intensive care unit: a 3-year study. Transpl Proc. 2014;46(9):3219\u201321.","journal-title":"Transpl Proc."},{"issue":"2","key":"249_CR41","doi-asserted-by":"crossref","first-page":"E72","DOI":"10.1111\/1469-0691.12091","volume":"19","author":"C Navarro-San Francisco","year":"2013","unstructured":"Navarro-San Francisco C, Mora-Rillo M, Romero-Gomez MP, et al. Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge. Clin Microbiol Infect. 2013;19(2):E72\u20139.","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"249_CR42","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/cid\/cis969","volume":"56","author":"F Sbrana","year":"2013","unstructured":"Sbrana F, Malacarne P, Viaggi B, et al. Carbapenem-sparing antibiotic regimens for infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in intensive care unit. Clin Infect Dis. 2013;56(5):697\u2013700.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"249_CR43","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1086\/649865","volume":"50","author":"M Souli","year":"2010","unstructured":"Souli M, Galani I, Antoniadou A, et al. An outbreak of infection due to beta-lactamase Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes. Clin Infect Dis. 2010;50(3):364\u201373.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"249_CR44","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/jac\/dku495","volume":"70","author":"D Duin van","year":"2015","unstructured":"van Duin D, Cober E, Richter SS, et al. Impact of therapy and strain type on outcomes in urinary tract infections caused by carbapenem-resistant Klebsiella pneumoniae. J Antimicrob Chemother. 2015;70(4):1203\u201311.","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"249_CR45","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3109\/00365548.2014.923106","volume":"46","author":"M Papadimitriou-Olivgeris","year":"2014","unstructured":"Papadimitriou-Olivgeris M, Marangos M, Christofidou M, et al. Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit. Scand J Infect Dis. 2014;46(9):642\u20138.","journal-title":"Scand J Infect Dis"},{"issue":"6","key":"249_CR46","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/tid.12450","volume":"17","author":"SM Pouch","year":"2015","unstructured":"Pouch SM, Kubin CJ, Satlin MJ, et al. Epidemiology and outcomes of carbapenem-resistant Klebsiella pneumoniae bacteriuria in kidney transplant recipients. Transpl Infect Dis. 2015;17(6):800\u20139.","journal-title":"Transpl Infect Dis."},{"issue":"1","key":"249_CR47","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1128\/AAC.05036-11","volume":"56","author":"I Sanchez-Romero","year":"2012","unstructured":"Sanchez-Romero I, Asensio A, Oteo J, et al. Nosocomial outbreak of VIM-1-producing Klebsiella pneumoniae isolates of multilocus sequence type 15: molecular basis, clinical risk factors, and outcome. Antimicrob Agents Chemother. 2012;56(1):420\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"249_CR48","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1111\/j.1469-0691.2011.03514.x","volume":"17","author":"O Zarkotou","year":"2011","unstructured":"Zarkotou O, Pournaras S, Tselioti P, et al. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect. 2011;17(12):1798\u2013803.","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"249_CR49","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1086\/588048","volume":"46","author":"C Urban","year":"2008","unstructured":"Urban C, Bradford PA, Tuckman M, et al. Carbapenem-resistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase beta-lactamases associated with long-term care facilities. Clin Infect Dis. 2008;46(11):e127\u201330.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"249_CR50","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3201\/eid1506.081735","volume":"15","author":"M McGuinn","year":"2009","unstructured":"McGuinn M, Hershow RC, Janda WM. Escherichia coli and Klebsiella pneumoniae carbapenemase in long-term care facility, Illinois, USA. Emerg Infect Dis. 2009;15(6):988\u20139.","journal-title":"Emerg Infect Dis."},{"issue":"2","key":"249_CR51","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/jac\/dkt392","volume":"69","author":"N Woodford","year":"2014","unstructured":"Woodford N, Wareham DW, Guerra B, Teale C. Carbapenemase-producing Enterobacteriaceae and non-Enterobacteriaceae from animals and the environment: an emerging public health risk of our own making? J Antimicrob Chemother. 2014;69(2):287\u201391.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"249_CR52","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1128\/JCM.00020-12","volume":"50","author":"D Gijon","year":"2012","unstructured":"Gijon D, Curiao T, Baquero F, Coque TM, Canton R. Fecal carriage of carbapenemase-producing Enterobacteriaceae: a hidden reservoir in hospitalized and non hospitalized patients. J Clin Microbiol. 2012;50(5):1558\u201363.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"249_CR53","doi-asserted-by":"crossref","first-page":"E23","DOI":"10.1111\/1469-0691.12070","volume":"19","author":"A Capone","year":"2013","unstructured":"Capone A, Giannella M, Fortini D, et al. High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality. Clin Microbiol Infect. 2013;19(1):E23\u201330.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"249_CR54","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1128\/AAC.01803-13","volume":"58","author":"L Villa","year":"2014","unstructured":"Villa L, Feudi C, Fortini D, Garcia-Fernandez A, Carattoli A. Genomics of KPC-producing Klebsiella pneumoniae sequence type 512 clone highlights the role of RamR and ribosomal S10 protein mutations in conferring tigecycline resistance. Antimicrob Agents Chemother. 2014;58(3):1707\u201312.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"249_CR55","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.cmi.2016.01.023","volume":"22","author":"C Hauck","year":"2016","unstructured":"Hauck C, Cober E, Richter SS, et al. Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections. Clin Microbiol Infect. 2016;22(6):513\u20139.","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"249_CR56","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1469-0691.2012.03823.x","volume":"18","author":"M Akova","year":"2012","unstructured":"Akova M, Daikos GL, Tzouvelekis L, Carmeli Y. Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria. Clin Microbiol Infect. 2012;18(5):439\u201348.","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"249_CR57","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ijantimicag.2016.02.015","volume":"47","author":"CS Abboud","year":"2016","unstructured":"Abboud CS, Monteiro J, Stryjewski ME, et al. Post-surgical mediastinitis due to carbapenem-resistant Enterobacteriaceae: clinical, epidemiological and survival characteristics. Int J Antimicrob Agents. 2016;47(5):386\u201390.","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"249_CR58","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1021\/jm900999h","volume":"53","author":"T Velkov","year":"2010","unstructured":"Velkov T, Thompson PE, Nation RL, Li J. Structure\u2013activity relationships of polymyxin antibiotics. J Med Chem. 2010;53(5):1898\u2013916.","journal-title":"J Med Chem"},{"issue":"5","key":"249_CR59","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1128\/JCM.02466-08","volume":"47","author":"J Lee","year":"2009","unstructured":"Lee J, Patel G, Huprikar S, Calfee DP, Jenkins SG. Decreased susceptibility to polymyxin B during treatment for carbapenem-resistant Klebsiella pneumoniae infection. J Clin Microbiol. 2009;47(5):1611\u20132.","journal-title":"J Clin Microbiol"},{"key":"249_CR60","unstructured":"Actavis. Actavis receives U.S. FDA approval for AVYCAZ\u2122 (CEFTAZIDIME\u2013AVIBACTAM). 2015. http:\/\/www.prnewswire.com\/news-releases\/actavis-receives-us-fda-approval-for-avycaz-ceftazidime-avibactam-300041592.html . Accessed 24 June 2016."},{"issue":"1","key":"249_CR61","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijantimicag.2015.02.022","volume":"46","author":"HS Sader","year":"2015","unstructured":"Sader HS, Castanheira M, Flamm RK, Mendes RE, Farrell DJ, Jones RN. Ceftazidime\/avibactam tested against Gram-negative bacteria from intensive care unit (ICU) and non-ICU patients, including those with ventilator-associated pneumonia. Int J Antimicrob Agents. 2015;46(1):53\u20139.","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"249_CR62","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1128\/AAC.00163-15","volume":"59","author":"M Castanheira","year":"2015","unstructured":"Castanheira M, Mills JC, Costello SE, Jones RN, Sader HS. Ceftazidime\u2013avibactam activity tested against Enterobacteriaceae isolates from U.S. hospitals (2011 to 2013) and characterization of beta-lactamase-producing strains. Antimicrob Agents Chemother. 2015;59(6):3509\u201317.","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"249_CR63","doi-asserted-by":"crossref","first-page":"7842","DOI":"10.1128\/AAC.02019-15","volume":"59","author":"S Vasoo","year":"2015","unstructured":"Vasoo S, Cunningham SA, Cole NC, et al. In Vitro Activities of ceftazidime\u2013avibactam, aztreonam\u2013avibactam, and a panel of older and contemporary antimicrobial agents against carbapenemase-producing gram-negative Bacilli. Antimicrob Agents Chemother. 2015;59(12):7842\u20136.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"249_CR64","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.nefro.2015.01.001","volume":"35","author":"F Caravaca-Fontan","year":"2015","unstructured":"Caravaca-Fontan F, Jimenez-Alvaro S, Marcen-Letosa R, Fernandez-Rodriguez A, Rodriguez-Navarro CQ. Ceftazidime\u2013avibactam in urinary tract infections due to carbapenemase-producing Klebsiella in kidney transplantation. Nefrologia. 2015;35(4):412\u20133.","journal-title":"Nefrologia."},{"issue":"2","key":"249_CR65","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ijantimicag.2016.06.002","volume":"48","author":"DM Jacobs","year":"2016","unstructured":"Jacobs DM, DiTursi S, Ruh C, et al. Combination treatment with extended-infusion ceftazidime\/avibactam for a KPC-3-producing Klebsiella pneumoniae bacteraemia in a kidney and pancreas transplant patient. Int J Antimicrob Agents. 2016;48(2):225\u20137.","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"249_CR66","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.idc.2016.02.007","volume":"30","author":"KM Papp-Wallace","year":"2016","unstructured":"Papp-Wallace KM, Bonomo RA. New beta-lactamase inhibitors in the clinic. Infect Dis Clin North Am. 2016;30(2):441\u201364.","journal-title":"Infect Dis Clin North Am"},{"issue":"4","key":"249_CR67","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1179\/1973947812Y.0000000015","volume":"24","author":"I Galani","year":"2012","unstructured":"Galani I, Souli M, Daikos GL, et al. Activity of plazomicin (ACHN-490) against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. from Athens, Greece. J Chemother. 2012;24(4):191\u20134.","journal-title":"J Chemother"},{"issue":"6","key":"249_CR68","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1128\/AAC.00436-16","volume":"60","author":"DM Livermore","year":"2016","unstructured":"Livermore DM, Mushtaq S, Warner M, Woodford N. In vitro activity of eravacycline against carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii. Antimicrob Agents Chemother. 2016;60(6):3840\u20134.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"249_CR69","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s40265-016-0545-8","volume":"76","author":"GG Zhanel","year":"2016","unstructured":"Zhanel GG, Cheung D, Adam H, et al. Review of eravacycline, a novel fluorocycline antibacterial agent. Drugs. 2016;76(5):567\u201388.","journal-title":"Drugs."}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-017-0249-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T14:14:26Z","timestamp":1751033666000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-017-0249-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,25]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["249"],"URL":"https:\/\/doi.org\/10.1186\/s12941-017-0249-2","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,25]]},"article-number":"76"}}